Palantir stands out with its scalable AI impact, unique Ontology platform, and defensible moat. Read why I think PLTR stock is a buy-on-pullback opportunity.

The CDC has already changed some vaccine guidelines, and the FDA may change others, which could throw insurance coverage into ...